NR4A2 (nuclear receptor subfamily 4 group A member 2) - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Gene: NR4A2 (nuclear receptor subfamily 4 group A member 2) Homo sapiens
Analyze
Symbol: NR4A2
Name: nuclear receptor subfamily 4 group A member 2
RGD ID: 732028
HGNC Page HGNC:7981
Description: Enables sequence-specific double-stranded DNA binding activity. Involved in DNA-templated transcription; negative regulation of apoptotic signaling pathway; and negative regulation of transcription by RNA polymerase II. Acts upstream of or within cellular response to extracellular stimulus. Located in nuclear speck. Implicated in Parkinson's disease.
Type: protein-coding
RefSeq Status: REVIEWED
Previously known as: HZF-3; IDLDP; immediate-early response protein NOT; intermediate-early receptor protein; NGFI-B/nur77 beta-type transcription factor homolog; NOT; nuclear receptor related 1; nuclear receptor subfamily 4, group A, member 2; nur related protein-1, human homolog of; NURR1; orphan nuclear receptor NR4A2; orphan nuclear receptor NURR1; RNR1; T-cell nuclear receptor NOT; TINUR; transcriptionally inducible nuclear receptor related 1; transcriptionally-inducible nuclear receptor
RGD Orthologs
Mouse
Rat
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh382156,324,437 - 156,332,721 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl2156,324,437 - 156,342,348 (-)EnsemblGRCh38hg38GRCh38
GRCh372157,180,949 - 157,189,233 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 362156,889,195 - 156,897,446 (-)NCBINCBI36Build 36hg18NCBI36
Build 342157,006,458 - 157,014,708NCBI
Celera2150,794,299 - 150,802,639 (-)NCBICelera
Cytogenetic Map2q24.1NCBI
HuRef2149,066,205 - 149,074,545 (-)NCBIHuRef
CHM1_12157,187,025 - 157,195,368 (-)NCBICHM1_1
T2T-CHM13v2.02156,777,128 - 156,785,409 (-)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(-)-demecolcine  (EXP)
(-)-epigallocatechin 3-gallate  (EXP)
1,2,4-trimethylbenzene  (ISO)
1,2-dichloroethane  (ISO)
1,2-dimethylhydrazine  (ISO)
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine  (ISO)
17beta-estradiol  (EXP,ISO)
2,2',4,4',5,5'-hexachlorobiphenyl  (ISO)
2,2',5,5'-tetrachlorobiphenyl  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2-hydroxypropanoic acid  (EXP)
2-palmitoylglycerol  (EXP)
3,4-methylenedioxymethamphetamine  (ISO)
3,7-dihydropurine-6-thione  (ISO)
4,4'-diaminodiphenylmethane  (ISO)
4,4'-sulfonyldiphenol  (EXP,ISO)
6-propyl-2-thiouracil  (ISO)
8-Br-cAMP  (EXP)
acetaldehyde  (EXP)
acrylamide  (EXP,ISO)
afimoxifene  (EXP)
aflatoxin B1  (EXP,ISO)
all-trans-retinoic acid  (EXP)
amiodarone  (EXP)
ammonium chloride  (ISO)
amodiaquine  (EXP)
antimycin A  (EXP)
arachidonic acid  (EXP)
aristolochic acid A  (EXP)
arsane  (EXP,ISO)
arsenic atom  (EXP,ISO)
arsenous acid  (EXP)
atrazine  (ISO)
benzalkonium chloride  (EXP)
benzene  (EXP)
benzo[a]pyrene  (ISO)
benzo[a]pyrene diol epoxide I  (EXP)
bifenthrin  (ISO)
bisphenol A  (EXP,ISO)
bisphenol F  (ISO)
buta-1,3-diene  (ISO)
butanal  (EXP)
C.I. Natural Red 20  (ISO)
cadmium atom  (EXP)
cadmium dichloride  (EXP)
Calcimycin  (ISO)
capecitabine  (EXP)
carbon nanotube  (ISO)
carmustine  (ISO)
Carnosol  (ISO)
CGP 52608  (EXP)
chloroquine  (EXP)
chlorpyrifos  (ISO)
choline  (ISO)
clozapine  (ISO)
cobalt dichloride  (EXP)
cocaine  (EXP)
colforsin daropate hydrochloride  (EXP)
copper(II) sulfate  (EXP)
corn oil  (ISO)
coumestrol  (EXP)
crocidolite asbestos  (EXP)
Cuprizon  (ISO)
curcumin  (EXP)
cyclosporin A  (EXP,ISO)
dabigatran  (ISO)
DDE  (EXP)
decabromodiphenyl ether  (ISO)
deguelin  (EXP)
dexamethasone  (EXP)
diarsenic trioxide  (EXP)
dibutyl phthalate  (ISO)
dieldrin  (EXP,ISO)
diheptyl phthalate  (ISO)
dipentyl phthalate  (ISO)
disodium selenite  (EXP)
dorsomorphin  (EXP)
doxorubicin  (EXP,ISO)
Enterolactone  (EXP)
epoxiconazole  (ISO)
fenvalerate  (ISO)
flavonoids  (ISO)
fluoranthene  (ISO)
fluoxetine  (ISO)
flutamide  (ISO)
folic acid  (ISO)
formaldehyde  (EXP)
gamma-hexachlorocyclohexane  (ISO)
geraniol  (EXP)
glafenine  (EXP)
glutathione  (ISO)
glycidol  (ISO)
GW 1929  (ISO)
heroin  (ISO)
hydroquinone  (EXP)
indometacin  (EXP)
iron dichloride  (EXP)
kainic acid  (ISO)
ketamine  (ISO)
L-gamma-glutamyl-L-cysteine  (ISO)
L-methionine  (ISO)
leptomycin B  (ISO)
lipopolysaccharide  (EXP)
lithium atom  (EXP)
lithium chloride  (ISO)
lithium hydride  (EXP)
lucanthone  (EXP)
maneb  (ISO)
medroxyprogesterone acetate  (EXP)
mercaptopurine  (ISO)
metformin  (ISO)
methamphetamine  (ISO)
methimazole  (ISO)
methotrexate  (EXP)
methylisothiazolinone  (EXP)
methylmercury chloride  (EXP,ISO)
mitoxantrone  (EXP)
mono(2-ethylhexyl) phthalate  (EXP)
monosodium L-glutamate  (ISO)
morphine  (ISO)
N(6)-butyryl-cAMP  (ISO)
N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide  (EXP)
N-methyl-4-phenylpyridinium  (ISO)
naphthalenes  (ISO)
nickel atom  (EXP)
nickel sulfate  (EXP)
nitrofen  (ISO)
ozone  (EXP)
paracetamol  (ISO)
paraquat  (ISO)
paricalcitol  (EXP)
PCB138  (ISO)
pentetrazol  (ISO)
perfluorooctane-1-sulfonic acid  (ISO)
perfluorooctanoic acid  (ISO)
permethrin  (EXP,ISO)
phencyclidine  (ISO)
phenformin  (ISO)
phorbol 13-acetate 12-myristate  (EXP)
phosphorus atom  (EXP)
phosphorus(.)  (EXP)
picoxystrobin  (EXP)
pirimiphos-methyl  (EXP)
pirinixic acid  (EXP,ISO)
potassium chloride  (ISO)
potassium chromate  (EXP)
pregnenolone 16alpha-carbonitrile  (ISO)
proanthocyanidin  (EXP)
probenecid  (ISO)
propanal  (EXP)
prostaglandin E2  (EXP,ISO)
purine-6-thiol  (ISO)
rac-lactic acid  (EXP)
reactive oxygen species  (EXP)
rotenone  (EXP,ISO)
S-(1,2-dichlorovinyl)-L-cysteine  (EXP)
SB 431542  (EXP)
SCH 23390  (ISO)
serpentine asbestos  (EXP)
Shikonin  (ISO)
silicon dioxide  (EXP,ISO)
silver atom  (ISO)
silver(0)  (ISO)
simazine  (ISO)
sodium arsenite  (EXP,ISO)
sodium dichromate  (ISO)
sodium dodecyl sulfate  (EXP)
sodium fluoride  (ISO)
Soman  (ISO)
styrene  (ISO)
sulfadimethoxine  (ISO)
tamoxifen  (ISO)
temozolomide  (EXP)
tetradecane  (ISO)
thalidomide  (EXP)
thapsigargin  (EXP)
Theaflavin 3,3'-digallate  (EXP)
thifluzamide  (EXP)
thimerosal  (EXP)
thioacetamide  (ISO)
titanium dioxide  (ISO)
topiramate  (ISO)
torcetrapib  (EXP)
triacsin C  (EXP)
trichostatin A  (EXP)
triphenylstannane  (ISO)
triptonide  (ISO)
troglitazone  (ISO)
trovafloxacin  (ISO)
undecane  (ISO)
urethane  (EXP)
valproic acid  (EXP,ISO)
vinclozolin  (ISO)
vitamin D  (ISO)
zinc atom  (EXP)
zinc(0)  (EXP)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
adult locomotory behavior  (IEA,ISO)
canonical Wnt signaling pathway  (TAS)
cellular response to corticotropin-releasing hormone stimulus  (IBA,IEA,ISS)
cellular response to oxidative stress  (IEA,ISO)
central nervous system neuron differentiation  (IBA,IEA,ISO)
central nervous system projection neuron axonogenesis  (IEA,ISO)
cerebral cortex development  (ISO)
DNA-templated transcription  (IDA,IEA)
dopamine biosynthetic process  (IEA,ISO)
dopamine metabolic process  (IEA,ISO)
dopaminergic neuron differentiation  (IBA,IEA,ISO,ISS)
fat cell differentiation  (IEA,ISS)
gene expression  (IEA,ISO)
general adaptation syndrome  (IEA,ISO)
habenula development  (IEA,ISO)
intracellular receptor signaling pathway  (IEA)
learning or memory  (ISO)
midbrain dopaminergic neuron differentiation  (TAS)
negative regulation of apoptotic signaling pathway  (IMP)
negative regulation of neuron apoptotic process  (IEA,ISO)
negative regulation of transcription by RNA polymerase II  (IMP,TAS)
nervous system development  (IEA,ISO)
neuron apoptotic process  (IEA,ISO)
neuron differentiation  (IEA,ISO)
neuron maturation  (IEA,ISO)
neuron migration  (IEA,ISO,TAS)
obsolete cellular response to extracellular stimulus  (IEA)
positive regulation of DNA-templated transcription  (IEA,ISO)
positive regulation of transcription by RNA polymerase II  (IEA,ISO,ISS,TAS)
post-embryonic development  (IEA,ISO)
regulation of DNA-templated transcription  (IEA,ISO)
regulation of dopamine metabolic process  (IEA,ISO)
regulation of gene expression  (IEA,ISO)
regulation of respiratory gaseous exchange  (IEA,ISO)
regulation of transcription by RNA polymerase II  (IBA,IEA)
response to amphetamine  (IEA,ISO)
response to hypoxia  (IEA,ISO)
response to inorganic substance  (ISO)
response to insecticide  (ISO)
retina development in camera-type eye  (ISO)
transcription by RNA polymerase II  (IEA,ISO)

Cellular Component

Molecular Pathway Annotations     Click to see Annotation Detail View
Phenotype Annotations     Click to see Annotation Detail View

Human Phenotype
Abnormal autonomic nervous system physiology  (IAGP)
Abnormal substantia nigra morphology  (IAGP)
Abnormality of extrapyramidal motor function  (IAGP)
Adult onset  (IAGP)
Akinesia  (IAGP)
Anxiety  (IAGP)
Ataxia  (IAGP)
Autism  (IAGP)
Autistic behavior  (IAGP)
Autosomal dominant inheritance  (IAGP)
Babinski sign  (IAGP)
Bilateral tonic-clonic seizure  (IAGP)
Bradykinesia  (IAGP)
Brisk reflexes  (IAGP)
Childhood onset  (IAGP)
Clumsiness  (IAGP)
Compulsive behaviors  (IAGP)
Constipation  (IAGP)
Decreased CSF homovanillic acid concentration  (IAGP)
Delayed speech and language development  (IAGP)
Dementia  (IAGP)
Depression  (IAGP)
Dysarthria  (IAGP)
Dysphagia  (IAGP)
Dystonia  (IAGP)
EMG: positive sharp waves  (IAGP)
Fatigue  (IAGP)
Feeding difficulties  (IAGP)
Focal dystonia  (IAGP)
Focal motor seizure  (IAGP)
Freezing of gait  (IAGP)
Gait ataxia  (IAGP)
Generalized dystonia  (IAGP)
Global developmental delay  (IAGP)
Hallucinations  (IAGP)
Hearing impairment  (IAGP)
Horizontal nystagmus  (IAGP)
Hypertension  (IAGP)
Hypothyroidism  (IAGP)
Impaired vibration sensation in the lower limbs  (IAGP)
Infantile onset  (IAGP)
Insidious onset  (IAGP)
Intellectual disability  (IAGP)
Intellectual disability, mild  (IAGP)
Late onset  (IAGP)
Lewy bodies  (IAGP)
Limb dystonia  (IAGP)
Lower limb hyperreflexia  (IAGP)
Mask-like facies  (IAGP)
Micrographia  (IAGP)
Neurodevelopmental delay  (IAGP)
Neuronal loss in central nervous system  (IAGP)
Paresis of extensor muscles of the big toe  (IAGP)
Parkinsonism  (IAGP)
Personality changes  (IAGP)
Pes cavus  (IAGP)
Postural instability  (IAGP)
Postural tremor  (IAGP)
Progressive  (IAGP)
Progressive flexion contractures  (IAGP)
Resting tremor  (IAGP)
Rheumatoid arthritis  (IAGP)
Rigidity  (IAGP)
Scoliosis  (IAGP)
Seizure  (IAGP)
Short stepped shuffling gait  (IAGP)
Sleep abnormality  (IAGP)
Sporadic  (IAGP)
Substantia nigra gliosis  (IAGP)
Talipes equinovarus  (IAGP)
Thinning of the substantia nigra pars compacta  (IAGP)
Torticollis  (IAGP)
Transient hyperphenylalaninemia  (IAGP)
Tremor  (IAGP)
Urinary urgency  (IAGP)
Weak voice  (IAGP)
References

References - curated
# Reference Title Reference Citation
1. Chronic Toxoplasma gondii in Nurr1-null heterozygous mice exacerbates elevated open field activity. Eells JB, etal., PLoS One. 2015 Apr 9;10(4):e0119280. doi: 10.1371/journal.pone.0119280. eCollection 2015.
2. GOAs Human GO annotations GOA_HUMAN data from the GO Consortium
3. Hypoxia-inducible factor 1 alpha and nuclear-related receptor 1 as targets for neuroprotection by albendazole in a rat rotenone model of Parkinson's disease. Kandil EA, etal., Clin Exp Pharmacol Physiol. 2019 Dec;46(12):1141-1150. doi: 10.1111/1440-1681.13162. Epub 2019 Sep 9.
4. Developmental Vitamin D (DVD) Deficiency Reduces Nurr1 and TH Expression in Post-mitotic Dopamine Neurons in Rat Mesencephalon. Luan W, etal., Mol Neurobiol. 2018 Mar;55(3):2443-2453. doi: 10.1007/s12035-017-0497-3. Epub 2017 Apr 1.
5. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
6. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
7. Rat nurr1 is prominently expressed in perirhinal cortex, and differentially induced in the hippocampal dentate gyrus by electroconvulsive vs. kindled seizures. Xing G, etal., Brain Res Mol Brain Res 1997 Jul;47(1-2):251-61.
8. Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease. Xu PY, etal., Neurology 2002 Mar 26;58(6):881-4.
Additional References at PubMed
PMID:7705655   PMID:7706727   PMID:7758108   PMID:7877627   PMID:8125298   PMID:10216261   PMID:10216262   PMID:11803525   PMID:11840500   PMID:11877444   PMID:11884470   PMID:11959923  
PMID:12477932   PMID:12496759   PMID:12564761   PMID:12627459   PMID:12694388   PMID:12756136   PMID:12774125   PMID:12815740   PMID:12827450   PMID:12852843   PMID:12875905   PMID:14525795  
PMID:14559918   PMID:14671317   PMID:14988426   PMID:15018843   PMID:15184637   PMID:15197702   PMID:15211629   PMID:15276233   PMID:15292355   PMID:15390059   PMID:15450088   PMID:15486232  
PMID:15489334   PMID:15548686   PMID:15604093   PMID:15635645   PMID:15635701   PMID:15961999   PMID:15964844   PMID:16223362   PMID:16243425   PMID:16293616   PMID:16320253   PMID:16344560  
PMID:16477036   PMID:16532445   PMID:16806233   PMID:16873729   PMID:16977628   PMID:17032747   PMID:17043312   PMID:17081983   PMID:17184956   PMID:17283078   PMID:17427185   PMID:17574328  
PMID:17671512   PMID:17681692   PMID:17728669   PMID:18057194   PMID:18195715   PMID:18242186   PMID:18292087   PMID:18463503   PMID:18577687   PMID:18583979   PMID:18684475   PMID:18937842  
PMID:18976975   PMID:19065535   PMID:19074857   PMID:19144721   PMID:19156841   PMID:19224617   PMID:19274049   PMID:19322201   PMID:19352218   PMID:19429166   PMID:19453261   PMID:19494806  
PMID:19549529   PMID:19569046   PMID:19570744   PMID:19671681   PMID:19692620   PMID:19732956   PMID:19861119   PMID:19913121   PMID:20016108   PMID:20049900   PMID:20195357   PMID:20301402  
PMID:20301446   PMID:20339536   PMID:20421523   PMID:20560679   PMID:20628086   PMID:20659174   PMID:20829434   PMID:21102462   PMID:21299892   PMID:21468021   PMID:21480782   PMID:21621845  
PMID:21757690   PMID:21826669   PMID:21873635   PMID:21936000   PMID:21979916   PMID:22024154   PMID:22066143   PMID:22143616   PMID:22230598   PMID:22275273   PMID:22294735   PMID:22309633  
PMID:22514272   PMID:22764233   PMID:22789442   PMID:22800541   PMID:22827504   PMID:22988876   PMID:23066323   PMID:23283970   PMID:23333304   PMID:23358114   PMID:23416839   PMID:23517088  
PMID:23679312   PMID:23803035   PMID:23809767   PMID:23821160   PMID:23933487   PMID:23950896   PMID:23977047   PMID:24005216   PMID:24086717   PMID:24115276   PMID:24172139   PMID:24223135  
PMID:24399192   PMID:24431302   PMID:24685177   PMID:24852325   PMID:25089663   PMID:25092869   PMID:25199433   PMID:25231870   PMID:25416956   PMID:25503547   PMID:25752609   PMID:25809189  
PMID:25917081   PMID:25953901   PMID:25982322   PMID:26022133   PMID:26148973   PMID:26239742   PMID:26678495   PMID:26871637   PMID:27036119   PMID:27121375   PMID:27128111   PMID:27159982  
PMID:27553040   PMID:27667480   PMID:27940361   PMID:28423575   PMID:28473536   PMID:28544326   PMID:28607006   PMID:28621822   PMID:28637666   PMID:28716280   PMID:28808448   PMID:29540663  
PMID:29738496   PMID:29770430   PMID:30106181   PMID:30121937   PMID:30504930   PMID:30515963   PMID:30817108   PMID:31428396   PMID:31515488   PMID:31704909   PMID:31723028   PMID:31811028  
PMID:31922365   PMID:32114387   PMID:32188741   PMID:32296183   PMID:32341238   PMID:32366965   PMID:32461025   PMID:32522891   PMID:32553196   PMID:32612143   PMID:32814053   PMID:33010383  
PMID:33188139   PMID:33563249   PMID:34248958   PMID:34437889   PMID:34667209   PMID:34672863   PMID:35272569   PMID:35296964   PMID:35409005   PMID:35582016   PMID:35761385   PMID:35797416  
PMID:35867766   PMID:35914814   PMID:36469101   PMID:36482877   PMID:36543142   PMID:36577072   PMID:37569656   PMID:37651006   PMID:37961948   PMID:38066638   PMID:38474099  


Genomics

Comparative Map Data
NR4A2
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh382156,324,437 - 156,332,721 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl2156,324,437 - 156,342,348 (-)EnsemblGRCh38hg38GRCh38
GRCh372157,180,949 - 157,189,233 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 362156,889,195 - 156,897,446 (-)NCBINCBI36Build 36hg18NCBI36
Build 342157,006,458 - 157,014,708NCBI
Celera2150,794,299 - 150,802,639 (-)NCBICelera
Cytogenetic Map2q24.1NCBI
HuRef2149,066,205 - 149,074,545 (-)NCBIHuRef
CHM1_12157,187,025 - 157,195,368 (-)NCBICHM1_1
T2T-CHM13v2.02156,777,128 - 156,785,409 (-)NCBIT2T-CHM13v2.0
Nr4a2
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm39256,996,845 - 57,014,152 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl256,996,842 - 57,014,015 (-)EnsemblGRCm39 Ensembl
GRCm38257,106,830 - 57,124,003 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl257,106,830 - 57,124,003 (-)EnsemblGRCm38mm10GRCm38
MGSCv37256,959,637 - 56,976,414 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv36256,923,542 - 56,930,641 (-)NCBIMGSCv36mm8
Celera258,866,926 - 58,883,671 (-)NCBICelera
Cytogenetic Map2C1.1NCBI
cM Map231.66NCBI
Nr4a2
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr8362,098,739 - 62,115,926 (-)NCBIGRCr8
mRatBN7.2341,689,847 - 41,707,036 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl341,689,851 - 41,697,877 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx345,028,318 - 45,033,797 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0353,613,078 - 53,618,558 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0351,404,666 - 51,410,139 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.0343,111,258 - 43,128,391 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl343,111,240 - 43,119,159 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.0348,183,106 - 48,192,467 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4338,866,205 - 38,871,678 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.1338,763,218 - 38,769,911 (-)NCBI
Celera339,783,304 - 39,788,777 (-)NCBICelera
Cytogenetic Map3q21NCBI
Nr4a2
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_00495544916,937,794 - 16,945,731 (+)EnsemblChiLan1.0
ChiLan1.0NW_00495544916,928,780 - 16,944,536 (+)NCBIChiLan1.0ChiLan1.0
NR4A2
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan1-v21358,993,305 - 59,002,614 (-)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan12B59,004,662 - 59,016,460 (-)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v02B43,584,835 - 43,593,118 (-)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.12B160,828,823 - 160,837,162 (-)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl2B160,826,091 - 160,837,162 (-)Ensemblpanpan1.1panPan2
NR4A2
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1362,546,237 - 2,554,559 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl362,547,421 - 2,552,780 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha362,678,764 - 2,696,690 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0362,664,920 - 2,682,769 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl362,665,580 - 2,671,459 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1362,663,962 - 2,681,849 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0362,724,009 - 2,741,835 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0362,763,654 - 2,781,495 (-)NCBIUU_Cfam_GSD_1.0
Nr4a2
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_024405303119,697,239 - 119,705,622 (-)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_00493646921,912,047 - 21,920,486 (+)EnsemblSpeTri2.0SpeTri2.0 Ensembl
SpeTri2.0NW_00493646921,912,118 - 21,920,486 (+)NCBISpeTri2.0SpeTri2.0SpeTri2.0
NR4A2
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl1563,487,731 - 63,495,299 (-)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.11563,487,051 - 63,506,249 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.21570,671,034 - 70,689,181 (-)NCBISscrofa10.2Sscrofa10.2susScr3
NR4A2
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.11041,715,092 - 41,724,411 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl1041,715,086 - 41,723,685 (-)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_023666040157,834,500 - 157,843,891 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0
Nr4a2
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_0046247329,581,779 - 9,589,942 (+)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_0046247329,572,160 - 9,589,624 (+)NCBIHetGla_female_1.0HetGla 1.0hetGla2

Variants

.
Variants in NR4A2
95 total Variants

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
NM_006186.4(NR4A2):c.-291del deletion Parkinson disease, late-onset [RCV000008118] Chr2:156332644 [GRCh38]
Chr2:157189156 [GRCh37]
Chr2:2q24.1		 likely pathogenic|uncertain significance
NM_006186.4(NR4A2):c.-245T>G single nucleotide variant Parkinson disease, late-onset [RCV000008119] Chr2:156332598 [GRCh38]
Chr2:157189110 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.15G>C (p.Gln5His) single nucleotide variant not provided [RCV003321158] Chr2:156330172 [GRCh38]
Chr2:157186684 [GRCh37]
Chr2:2q24.1		 uncertain significance
GRCh38/hg38 2q24.1-24.3(chr2:154366788-167048902)x3 copy number gain See cases [RCV000052950] Chr2:154366788..167048902 [GRCh38]
Chr2:155223300..167905412 [GRCh37]
Chr2:154931546..167613658 [NCBI36]
Chr2:2q24.1-24.3		 pathogenic
GRCh38/hg38 2q22.3-24.1(chr2:147251948-157856378)x1 copy number loss See cases [RCV000054090] Chr2:147251948..157856378 [GRCh38]
Chr2:148009516..158712890 [GRCh37]
Chr2:147725986..158421136 [NCBI36]
Chr2:2q22.3-24.1		 pathogenic
GRCh38/hg38 2q23.1-24.3(chr2:148917286-163204623)x1 copy number loss See cases [RCV000054093] Chr2:148917286..163204623 [GRCh38]
Chr2:149674855..164061133 [GRCh37]
Chr2:149391325..163769379 [NCBI36]
Chr2:2q23.1-24.3		 pathogenic
NM_006186.3(NR4A2):c.252C>T (p.Ser84=) single nucleotide variant Malignant melanoma [RCV000065127] Chr2:156329935 [GRCh38]
Chr2:157186447 [GRCh37]
Chr2:156894693 [NCBI36]
Chr2:2q24.1		 not provided
NM_006186.4(NR4A2):c.598_601dup (p.Pro201fs) duplication Autism spectrum disorder [RCV001291378] Chr2:156329585..156329586 [GRCh38]
Chr2:157186097..157186098 [GRCh37]
Chr2:2q24.1		 likely pathogenic
GRCh38/hg38 2q22.3-24.1(chr2:143900149-158321624)x3 copy number gain See cases [RCV000135402] Chr2:143900149..158321624 [GRCh38]
Chr2:144657717..159178136 [GRCh37]
Chr2:144374187..158886382 [NCBI36]
Chr2:2q22.3-24.1		 pathogenic
GRCh38/hg38 2q24.1-31.1(chr2:154294042-175989372)x3 copy number gain See cases [RCV000142286] Chr2:154294042..175989372 [GRCh38]
Chr2:155150555..176854100 [GRCh37]
Chr2:154858801..176562346 [NCBI36]
Chr2:2q24.1-31.1		 pathogenic
GRCh38/hg38 2q23.3-24.1(chr2:153609714-158185125)x1 copy number loss See cases [RCV000142963] Chr2:153609714..158185125 [GRCh38]
Chr2:154466227..159041637 [GRCh37]
Chr2:154174473..158749883 [NCBI36]
Chr2:2q23.3-24.1		 pathogenic
GRCh38/hg38 2q23.3-24.2(chr2:151932344-159419734)x1 copy number loss See cases [RCV000142664] Chr2:151932344..159419734 [GRCh38]
Chr2:152788858..160276245 [GRCh37]
Chr2:152497104..159984491 [NCBI36]
Chr2:2q23.3-24.2		 pathogenic|likely pathogenic
NM_006186.4(NR4A2):c.*1198C>T single nucleotide variant Parkinson disease, late-onset [RCV000261252] Chr2:156324546 [GRCh38]
Chr2:157181058 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.585C>T (p.Asp195=) single nucleotide variant Parkinson disease, late-onset [RCV000394445] Chr2:156329602 [GRCh38]
Chr2:157186114 [GRCh37]
Chr2:2q24.1		 likely benign|uncertain significance
NM_006186.4(NR4A2):c.-223C>T single nucleotide variant Parkinson disease, late-onset [RCV000259760] Chr2:156332576 [GRCh38]
Chr2:157189088 [GRCh37]
Chr2:2q24.1		 likely benign
NM_006186.4(NR4A2):c.1158+13C>T single nucleotide variant Parkinson disease, late-onset [RCV000405563] Chr2:156327838 [GRCh38]
Chr2:157184350 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.357G>T (p.Ser119=) single nucleotide variant Autism [RCV000195213] Chr2:156329830 [GRCh38]
Chr2:157186342 [GRCh37]
Chr2:2q24.1		 benign
NM_006186.4(NR4A2):c.732C>A (p.Leu244=) single nucleotide variant NR4A2-related condition [RCV003922420]|Parkinson disease, late-onset [RCV000303009]|not provided [RCV000882820] Chr2:156329455 [GRCh38]
Chr2:157185967 [GRCh37]
Chr2:2q24.1		 benign|likely benign
Single allele deletion Autism spectrum disorder [RCV000225489] Chr2:154507239..157810705 [GRCh38]
Chr2:155363751..158667217 [GRCh37]
Chr2:2q24.1		 likely pathogenic
NM_006186.4(NR4A2):c.657T>C (p.Ala219=) single nucleotide variant Parkinson disease, late-onset [RCV000357837]|not provided [RCV003430837] Chr2:156329530 [GRCh38]
Chr2:157186042 [GRCh37]
Chr2:2q24.1		 likely benign|uncertain significance
GRCh37/hg19 2q24.1-31.3(chr2:156489430-182921298)x3 copy number gain See cases [RCV000239848] Chr2:156489430..182921298 [GRCh37]
Chr2:2q24.1-31.3		 pathogenic
NM_006186.4(NR4A2):c.*659_*661del deletion Parkinson Disease, Dominant/Recessive [RCV000280528]|not provided [RCV003430836] Chr2:156325083..156325085 [GRCh38]
Chr2:157181595..157181597 [GRCh37]
Chr2:2q24.1		 likely benign|uncertain significance
NM_006186.4(NR4A2):c.*933G>A single nucleotide variant Parkinson disease, late-onset [RCV000316517] Chr2:156324811 [GRCh38]
Chr2:157181323 [GRCh37]
Chr2:2q24.1		 likely benign|uncertain significance
NM_006186.4(NR4A2):c.-166C>G single nucleotide variant Parkinson disease, late-onset [RCV000354613] Chr2:156332519 [GRCh38]
Chr2:157189031 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.*352C>A single nucleotide variant Parkinson disease, late-onset [RCV000385507] Chr2:156325392 [GRCh38]
Chr2:157181904 [GRCh37]
Chr2:2q24.1		 benign|likely benign
NM_006186.4(NR4A2):c.-241C>G single nucleotide variant Parkinson disease, late-onset [RCV000368568] Chr2:156332594 [GRCh38]
Chr2:157189106 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.*331T>G single nucleotide variant Parkinson disease, late-onset [RCV000295649] Chr2:156325413 [GRCh38]
Chr2:157181925 [GRCh37]
Chr2:2q24.1		 benign
NM_006186.4(NR4A2):c.*400CA[9] microsatellite Parkinson Disease, Dominant/Recessive [RCV000331043] Chr2:156325325..156325326 [GRCh38]
Chr2:157181837..157181838 [GRCh37]
Chr2:2q24.1		 benign
NM_006186.4(NR4A2):c.*192C>G single nucleotide variant Parkinson disease, late-onset [RCV000350620] Chr2:156325552 [GRCh38]
Chr2:157182064 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.-325C>G single nucleotide variant Parkinson disease, late-onset [RCV000273828] Chr2:156332678 [GRCh38]
Chr2:157189190 [GRCh37]
Chr2:2q24.1		 uncertain significance
GRCh37/hg19 2p25.3-q37.3(chr2:14238-243048760)x3 copy number gain not provided [RCV000752802] Chr2:14238..243048760 [GRCh37]
Chr2:2p25.3-q37.3		 pathogenic
NM_006186.4(NR4A2):c.1426G>C (p.Val476Leu) single nucleotide variant Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism [RCV003315187] Chr2:156326264 [GRCh38]
Chr2:157182776 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.-144G>A single nucleotide variant Parkinson disease, late-onset [RCV000304357] Chr2:156332497 [GRCh38]
Chr2:157189009 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.1635G>T (p.Gly545=) single nucleotide variant Parkinson disease, late-onset [RCV000347476] Chr2:156325906 [GRCh38]
Chr2:157182418 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.3(NR4A2):c.-384T>C single nucleotide variant Parkinson disease, late-onset [RCV000333539] Chr2:156332737 [GRCh38]
Chr2:157189249 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.-227C>G single nucleotide variant Parkinson disease, late-onset [RCV000318518] Chr2:156332580 [GRCh38]
Chr2:157189092 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.3(NR4A2):c.-387A>T single nucleotide variant Parkinson Disease, Dominant/Recessive [RCV000388031] Chr2:156332740 [GRCh38]
Chr2:157189252 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.1659C>G (p.Ser553=) single nucleotide variant Parkinson disease, late-onset [RCV000287586] Chr2:156325882 [GRCh38]
Chr2:157182394 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.1746G>A (p.Val582=) single nucleotide variant Parkinson disease, late-onset [RCV000392537] Chr2:156325795 [GRCh38]
Chr2:157182307 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.*822A>C single nucleotide variant Parkinson disease, late-onset [RCV000375093] Chr2:156324922 [GRCh38]
Chr2:157181434 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.3(NR4A2):c.*1311A>G single nucleotide variant Parkinson disease, late-onset [RCV000360741] Chr2:156324433 [GRCh38]
Chr2:157180945 [GRCh37]
Chr2:2q24.1		 uncertain significance
GRCh37/hg19 2p25.3-q37.3(chr2:12771-242783384) copy number gain See cases [RCV000512056] Chr2:12771..242783384 [GRCh37]
Chr2:2p25.3-q37.3		 pathogenic
GRCh37/hg19 2p25.3-q37.3(chr2:12771-242783384)x3 copy number gain See cases [RCV000511212] Chr2:12771..242783384 [GRCh37]
Chr2:2p25.3-q37.3		 pathogenic
NM_006186.4(NR4A2):c.327dup (p.Ser110fs) duplication Epilepsy [RCV000656523] Chr2:156329859..156329860 [GRCh38]
Chr2:157186371..157186372 [GRCh37]
Chr2:2q24.1		 likely pathogenic
GRCh37/hg19 2q12.1-24.3(chr2:104172062-168223828)x1 copy number loss Poly (ADP-Ribose) polymerase inhibitor response [RCV000626436] Chr2:104172062..168223828 [GRCh37]
Chr2:2q12.1-24.3		 drug response
GRCh37/hg19 2p25.3-q37.3(chr2:15672-243101834)x3 copy number gain not provided [RCV000752804] Chr2:15672..243101834 [GRCh37]
Chr2:2p25.3-q37.3		 pathogenic
GRCh37/hg19 2q23.3-31.2(chr2:152409978-179325736)x3 copy number gain not provided [RCV000740654] Chr2:152409978..179325736 [GRCh37]
Chr2:2q23.3-31.2		 pathogenic
NM_006186.4(NR4A2):c.489C>A (p.Ile163=) single nucleotide variant not provided [RCV000891735] Chr2:156329698 [GRCh38]
Chr2:157186210 [GRCh37]
Chr2:2q24.1		 benign
NM_006186.4(NR4A2):c.75C>T (p.His25=) single nucleotide variant not provided [RCV000921132] Chr2:156330112 [GRCh38]
Chr2:157186624 [GRCh37]
Chr2:2q24.1		 likely benign
NM_006186.4(NR4A2):c.1047G>C (p.Pro349=) single nucleotide variant not provided [RCV000936304] Chr2:156327962 [GRCh38]
Chr2:157184474 [GRCh37]
Chr2:2q24.1		 likely benign
GRCh37/hg19 2p25.3-q37.3(chr2:1-243199373) copy number gain Mosaic trisomy 2 [RCV002280628] Chr2:1..243199373 [GRCh37]
Chr2:2p25.3-q37.3		 pathogenic
NM_006186.4(NR4A2):c.1638G>A (p.Leu546=) single nucleotide variant Parkinson disease, late-onset [RCV001131971] Chr2:156325903 [GRCh38]
Chr2:157182415 [GRCh37]
Chr2:2q24.1		 likely benign
NM_006186.4(NR4A2):c.1273C>T (p.Pro425Ser) single nucleotide variant Parkinson disease, late-onset [RCV001132917] Chr2:156326806 [GRCh38]
Chr2:157183318 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.325C>G (p.Gln109Glu) single nucleotide variant Parkinson disease, late-onset [RCV001136356] Chr2:156329862 [GRCh38]
Chr2:157186374 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.1163A>T (p.Gln388Leu) single nucleotide variant Parkinson disease, late-onset [RCV001132920] Chr2:156326916 [GRCh38]
Chr2:157183428 [GRCh37]
Chr2:2q24.1		 uncertain significance
GRCh37/hg19 2q24.1(chr2:157124370-157470128)x1 copy number loss not provided [RCV000847405] Chr2:157124370..157470128 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.947A>G (p.Gln316Arg) single nucleotide variant Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism [RCV003219203] Chr2:156328451 [GRCh38]
Chr2:157184963 [GRCh37]
Chr2:2q24.1		 uncertain significance
GRCh37/hg19 2q22.3-24.1(chr2:147173792-158346266)x1 copy number loss not provided [RCV001005326] Chr2:147173792..158346266 [GRCh37]
Chr2:2q22.3-24.1		 pathogenic
GRCh37/hg19 2q24.1(chr2:156773914-157954702)x3 copy number gain not provided [RCV000849189] Chr2:156773914..157954702 [GRCh37]
Chr2:2q24.1		 uncertain significance
GRCh37/hg19 2q24.1(chr2:157170397-157846289)x3 copy number gain not provided [RCV001005345] Chr2:157170397..157846289 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.968G>T (p.Cys323Phe) single nucleotide variant not provided [RCV001217156] Chr2:156328430 [GRCh38]
Chr2:157184942 [GRCh37]
Chr2:2q24.1		 pathogenic|uncertain significance
NM_006186.4(NR4A2):c.881dup (p.Asn294fs) duplication Parkinson disease, late-onset [RCV001196350] Chr2:156328516..156328517 [GRCh38]
Chr2:157185028..157185029 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.1548C>T (p.His516=) single nucleotide variant Parkinson disease, late-onset [RCV001132916] Chr2:156325993 [GRCh38]
Chr2:157182505 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.1170C>A (p.Asn390Lys) single nucleotide variant Parkinson disease, late-onset [RCV001132919] Chr2:156326909 [GRCh38]
Chr2:157183421 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.1566G>T (p.Lys522Asn) single nucleotide variant Autism spectrum disorder [RCV003127336] Chr2:156325975 [GRCh38]
Chr2:157182487 [GRCh37]
Chr2:2q24.1		 likely benign
NM_006186.4(NR4A2):c.1405del (p.Val469fs) deletion Developmental disorder [RCV003127337] Chr2:156326285 [GRCh38]
Chr2:157182797 [GRCh37]
Chr2:2q24.1		 likely pathogenic
NM_006186.4(NR4A2):c.819A>G (p.Gln273=) single nucleotide variant not provided [RCV000930292] Chr2:156329368 [GRCh38]
Chr2:157185880 [GRCh37]
Chr2:2q24.1		 likely benign
NM_006186.4(NR4A2):c.1108A>C (p.Arg370=) single nucleotide variant not provided [RCV000930355] Chr2:156327901 [GRCh38]
Chr2:157184413 [GRCh37]
Chr2:2q24.1		 likely benign
NM_006186.4(NR4A2):c.1467C>T (p.Phe489=) single nucleotide variant not provided [RCV000938564] Chr2:156326223 [GRCh38]
Chr2:157182735 [GRCh37]
Chr2:2q24.1		 likely benign
NM_006186.4(NR4A2):c.*1017T>C single nucleotide variant Parkinson disease, late-onset [RCV001129265] Chr2:156324727 [GRCh38]
Chr2:157181239 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.-253C>T single nucleotide variant Parkinson disease, late-onset [RCV001129364] Chr2:156332606 [GRCh38]
Chr2:157189118 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.1588A>C (p.Lys530Gln) single nucleotide variant Parkinson disease, late-onset [RCV001131972] Chr2:156325953 [GRCh38]
Chr2:157182465 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.1230G>A (p.Leu410=) single nucleotide variant Parkinson disease, late-onset [RCV001132918] Chr2:156326849 [GRCh38]
Chr2:157183361 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.1494_1497dup (p.Ile500fs) duplication not provided [RCV000997240] Chr2:156326192..156326193 [GRCh38]
Chr2:157182704..157182705 [GRCh37]
Chr2:2q24.1		 likely pathogenic
NM_006186.4(NR4A2):c.1235G>T (p.Gly412Val) single nucleotide variant not provided [RCV003237111] Chr2:156326844 [GRCh38]
Chr2:157183356 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.325C>A (p.Gln109Lys) single nucleotide variant Parkinson disease, late-onset [RCV001136357] Chr2:156329862 [GRCh38]
Chr2:157186374 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.-304C>T single nucleotide variant Parkinson disease, late-onset [RCV001129365] Chr2:156332657 [GRCh38]
Chr2:157189169 [GRCh37]
Chr2:2q24.1		 uncertain significance
GRCh37/hg19 2q24.1(chr2:157117939-158422574)x1 copy number loss not provided [RCV001005344] Chr2:157117939..158422574 [GRCh37]
Chr2:2q24.1		 likely pathogenic
NM_006186.4(NR4A2):c.360T>G (p.Val120=) single nucleotide variant Parkinson disease, late-onset [RCV001136355] Chr2:156329827 [GRCh38]
Chr2:157186339 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.591C>A (p.Pro197=) single nucleotide variant Parkinson disease, late-onset [RCV001136353] Chr2:156329596 [GRCh38]
Chr2:157186108 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.372C>T (p.Pro124=) single nucleotide variant Parkinson disease, late-onset [RCV001136354] Chr2:156329815 [GRCh38]
Chr2:157186327 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.*1249A>G single nucleotide variant Parkinson disease, late-onset [RCV001129264] Chr2:156324495 [GRCh38]
Chr2:157181007 [GRCh37]
Chr2:2q24.1		 likely benign
NM_006186.4(NR4A2):c.*599T>G single nucleotide variant Parkinson disease, late-onset [RCV001129266] Chr2:156325145 [GRCh38]
Chr2:157181657 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.3(NR4A2):c.-437A>G single nucleotide variant Parkinson disease, late-onset [RCV001132086] Chr2:156332790 [GRCh38]
Chr2:157189302 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.825C>A (p.Tyr275Ter) single nucleotide variant not provided [RCV001091992] Chr2:156329362 [GRCh38]
Chr2:157185874 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.-339C>A single nucleotide variant Parkinson disease, late-onset [RCV001129366] Chr2:156332692 [GRCh38]
Chr2:157189204 [GRCh37]
Chr2:2q24.1		 uncertain significance
GRCh37/hg19 2q24.1(chr2:156696086-159450561)x1 copy number loss not provided [RCV001259776] Chr2:156696086..159450561 [GRCh37]
Chr2:2q24.1		 likely pathogenic
NC_000002.12:g.156333107dup duplication not provided [RCV001619173] Chr2:156333105..156333106 [GRCh38]
Chr2:157189617..157189618 [GRCh37]
Chr2:2q24.1		 benign
NM_006186.4(NR4A2):c.79T>C (p.Ser27Pro) single nucleotide variant not provided [RCV001727159] Chr2:156330108 [GRCh38]
Chr2:157186620 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.896G>T (p.Cys299Phe) single nucleotide variant Parkinson disease, late-onset [RCV002250155] Chr2:156328502 [GRCh38]
Chr2:157185014 [GRCh37]
Chr2:2q24.1		 pathogenic
NM_006186.4(NR4A2):c.386C>A (p.Thr129Lys) single nucleotide variant not provided [RCV001760883] Chr2:156329801 [GRCh38]
Chr2:157186313 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.289A>G (p.Met97Val) single nucleotide variant NR4A2-related condition [RCV003903636]|not provided [RCV003883797]|not specified [RCV002248056] Chr2:156329898 [GRCh38]
Chr2:157186410 [GRCh37]
Chr2:2q24.1		 likely benign|uncertain significance
NM_006186.4(NR4A2):c.1423T>A (p.Cys475Ser) single nucleotide variant not provided [RCV001763050] Chr2:156326267 [GRCh38]
Chr2:157182779 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.1167del (p.Asn390fs) deletion not provided [RCV001752459] Chr2:156326912 [GRCh38]
Chr2:157183424 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.326dup (p.Ser110fs) duplication Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism [RCV002260708]|not provided [RCV001768603] Chr2:156329860..156329861 [GRCh38]
Chr2:157186372..157186373 [GRCh37]
Chr2:2q24.1		 pathogenic|uncertain significance
NM_006186.4(NR4A2):c.1764T>G (p.Ile588Met) single nucleotide variant not provided [RCV001758202] Chr2:156325777 [GRCh38]
Chr2:157182289 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.1670G>C (p.Gly557Ala) single nucleotide variant Complex neurodevelopmental disorder [RCV001801259] Chr2:156325871 [GRCh38]
Chr2:157182383 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.1157_1158insCCTGGACTAGACCAGCCTGGACTATTCCAG (p.Arg386delinsSerLeuAspTer) insertion Global developmental delay [RCV001779399] Chr2:156327851..156327852 [GRCh38]
Chr2:157184363..157184364 [GRCh37]
Chr2:2q24.1		 likely pathogenic
NM_006186.4(NR4A2):c.1576G>T (p.Glu526Ter) single nucleotide variant History of neurodevelopmental disorder [RCV001825194] Chr2:156325965 [GRCh38]
Chr2:157182477 [GRCh37]
Chr2:2q24.1		 not provided
GRCh37/hg19 2q24.1(chr2:157058119-157183736)x1 copy number loss Complex neurodevelopmental disorder [RCV001823861] Chr2:157058119..157183736 [GRCh37]
Chr2:2q24.1		 pathogenic
GRCh37/hg19 2q23.3-24.2(chr2:152967964-160089210)x3 copy number gain not provided [RCV001825170] Chr2:152967964..160089210 [GRCh37]
Chr2:2q23.3-24.2		 not provided
GRCh37/hg19 2q23.3-24.1(chr2:154328530-158759642)x1 copy number loss not provided [RCV001827767] Chr2:154328530..158759642 [GRCh37]
Chr2:2q23.3-24.1		 pathogenic
GRCh37/hg19 2q23.3-24.1(chr2:154852961-159126250)x1 copy number loss not provided [RCV001827793] Chr2:154852961..159126250 [GRCh37]
Chr2:2q23.3-24.1		 pathogenic
NM_006186.4(NR4A2):c.308A>G (p.His103Arg) single nucleotide variant not specified [RCV002248055] Chr2:156329879 [GRCh38]
Chr2:157186391 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.325del (p.Gln109fs) deletion Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism [RCV003151948] Chr2:156329862 [GRCh38]
Chr2:157186374 [GRCh37]
Chr2:2q24.1		 likely pathogenic
NM_006186.4(NR4A2):c.158C>T (p.Ala53Val) single nucleotide variant not provided [RCV002244484] Chr2:156330029 [GRCh38]
Chr2:157186541 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.281A>T (p.Asp94Val) single nucleotide variant not provided [RCV002273695] Chr2:156329906 [GRCh38]
Chr2:157186418 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.1118T>G (p.Val373Gly) single nucleotide variant not provided [RCV002274768] Chr2:156327891 [GRCh38]
Chr2:157184403 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.698del (p.Pro233fs) deletion Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism [RCV002291393] Chr2:156329489 [GRCh38]
Chr2:157186001 [GRCh37]
Chr2:2q24.1		 pathogenic
NM_006186.4(NR4A2):c.1144C>G (p.Leu382Val) single nucleotide variant not provided [RCV002275820] Chr2:156327865 [GRCh38]
Chr2:157184377 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.914G>A (p.Cys305Tyr) single nucleotide variant Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism [RCV002260904] Chr2:156328484 [GRCh38]
Chr2:157184996 [GRCh37]
Chr2:2q24.1		 pathogenic
NM_006186.4(NR4A2):c.956G>A (p.Arg319Gln) single nucleotide variant Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism [RCV002260905] Chr2:156328442 [GRCh38]
Chr2:157184954 [GRCh37]
Chr2:2q24.1		 pathogenic
NM_006186.4(NR4A2):c.839G>A (p.Cys280Tyr) single nucleotide variant Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism [RCV002260903] Chr2:156329348 [GRCh38]
Chr2:157185860 [GRCh37]
Chr2:2q24.1		 pathogenic
NM_006186.4(NR4A2):c.943T>C (p.Cys315Arg) single nucleotide variant Neurodevelopmental delay [RCV002274361] Chr2:156328455 [GRCh38]
Chr2:157184967 [GRCh37]
Chr2:2q24.1		 likely pathogenic
NM_006186.4(NR4A2):c.64T>C (p.Tyr22His) single nucleotide variant not provided [RCV002469559] Chr2:156330123 [GRCh38]
Chr2:157186635 [GRCh37]
Chr2:2q24.1		 uncertain significance
GRCh37/hg19 2q24.1(chr2:156528912-158233672)x3 copy number gain not provided [RCV002472484] Chr2:156528912..158233672 [GRCh37]
Chr2:2q24.1		 uncertain significance
GRCh37/hg19 2q24.1(chr2:156996368-157372032)x1 copy number loss not provided [RCV002472516] Chr2:156996368..157372032 [GRCh37]
Chr2:2q24.1		 likely pathogenic
NM_006186.4(NR4A2):c.1786_1787del (p.Leu596fs) deletion not provided [RCV002300943] Chr2:156325754..156325755 [GRCh38]
Chr2:157182266..157182267 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.605T>C (p.Met202Thr) single nucleotide variant Inborn genetic diseases [RCV002773204] Chr2:156329582 [GRCh38]
Chr2:157186094 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.994+3A>G single nucleotide variant Inborn genetic diseases [RCV002865514] Chr2:156328401 [GRCh38]
Chr2:157184913 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.854G>A (p.Gly285Asp) single nucleotide variant Complex neurodevelopmental disorder [RCV002795916] Chr2:156329333 [GRCh38]
Chr2:157185845 [GRCh37]
Chr2:2q24.1		 likely pathogenic
NM_006186.4(NR4A2):c.368A>G (p.Lys123Arg) single nucleotide variant Inborn genetic diseases [RCV002737632] Chr2:156329819 [GRCh38]
Chr2:157186331 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.665A>G (p.Asn222Ser) single nucleotide variant Inborn genetic diseases [RCV002644799] Chr2:156329522 [GRCh38]
Chr2:157186034 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.551G>C (p.Gly184Ala) single nucleotide variant Inborn genetic diseases [RCV002826826] Chr2:156329636 [GRCh38]
Chr2:157186148 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.755C>A (p.Pro252Gln) single nucleotide variant Inborn genetic diseases [RCV002673889] Chr2:156329432 [GRCh38]
Chr2:157185944 [GRCh37]
Chr2:2q24.1		 likely benign
NM_006186.4(NR4A2):c.892G>T (p.Val298Leu) single nucleotide variant Inborn genetic diseases [RCV002855355] Chr2:156328506 [GRCh38]
Chr2:157185018 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.353G>C (p.Gly118Ala) single nucleotide variant Inborn genetic diseases [RCV003181005] Chr2:156329834 [GRCh38]
Chr2:157186346 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.863A>G (p.Lys288Arg) single nucleotide variant Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism [RCV003223543] Chr2:156329324 [GRCh38]
Chr2:157185836 [GRCh37]
Chr2:2q24.1		 likely pathogenic
NM_006186.4(NR4A2):c.899T>C (p.Leu300Ser) single nucleotide variant Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism [RCV003133074] Chr2:156328499 [GRCh38]
Chr2:157185011 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.591_592del (p.Leu198fs) deletion Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism [RCV003322656] Chr2:156329595..156329596 [GRCh38]
Chr2:157186107..157186108 [GRCh37]
Chr2:2q24.1		 pathogenic
NM_006186.4(NR4A2):c.1579C>G (p.Leu527Val) single nucleotide variant not provided [RCV003330040] Chr2:156325962 [GRCh38]
Chr2:157182474 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.863A>C (p.Lys288Thr) single nucleotide variant Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism [RCV003325933] Chr2:156329324 [GRCh38]
Chr2:157185836 [GRCh37]
Chr2:2q24.1		 likely pathogenic
NM_006186.4(NR4A2):c.604A>G (p.Met202Val) single nucleotide variant Inborn genetic diseases [RCV003343150] Chr2:156329583 [GRCh38]
Chr2:157186095 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.1159-3C>T single nucleotide variant not specified [RCV003331784] Chr2:156326923 [GRCh38]
Chr2:157183435 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.822C>G (p.His274Gln) single nucleotide variant Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism [RCV003333476] Chr2:156329365 [GRCh38]
Chr2:157185877 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.854G>T (p.Gly285Val) single nucleotide variant Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism [RCV003333338] Chr2:156329333 [GRCh38]
Chr2:157185845 [GRCh37]
Chr2:2q24.1		 likely pathogenic
NM_006186.4(NR4A2):c.798T>G (p.Cys266Trp) single nucleotide variant not provided [RCV003332835] Chr2:156329389 [GRCh38]
Chr2:157185901 [GRCh37]
Chr2:2q24.1		 uncertain significance
NC_000002.12:g.156238340T>C single nucleotide variant not provided [RCV003429306] Chr2:156238340 [GRCh38]
Chr2:157094852 [GRCh37]
Chr2:2q24.1		 benign
GRCh37/hg19 2q24.1(chr2:156828817-158377885)x1 copy number loss not provided [RCV003485116] Chr2:156828817..158377885 [GRCh37]
Chr2:2q24.1		 pathogenic
NM_006186.4(NR4A2):c.1287C>T (p.Asp429=) single nucleotide variant not provided [RCV003429307] Chr2:156326792 [GRCh38]
Chr2:157183304 [GRCh37]
Chr2:2q24.1		 likely benign
NM_006186.4(NR4A2):c.1255G>T (p.Gly419Cys) single nucleotide variant NR4A2-related condition [RCV003416786] Chr2:156326824 [GRCh38]
Chr2:157183336 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.709_711del (p.Ile237del) deletion NR4A2-related condition [RCV003414481] Chr2:156329476..156329478 [GRCh38]
Chr2:157185988..157185990 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.717C>T (p.His239=) single nucleotide variant not provided [RCV003429308] Chr2:156329470 [GRCh38]
Chr2:157185982 [GRCh37]
Chr2:2q24.1		 benign
NM_006186.4(NR4A2):c.934C>T (p.Arg312Trp) single nucleotide variant Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism [RCV003494082] Chr2:156328464 [GRCh38]
Chr2:157184976 [GRCh37]
Chr2:2q24.1		 likely pathogenic
NC_000002.12:g.156332819T>A single nucleotide variant NR4A2-related condition [RCV003981823] Chr2:156332819 [GRCh38]
Chr2:157189331 [GRCh37]
Chr2:2q24.1		 likely benign
NM_006186.4(NR4A2):c.1789C>T (p.Pro597Ser) single nucleotide variant Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism [RCV003989049] Chr2:156325752 [GRCh38]
Chr2:157182264 [GRCh37]		 uncertain significance
NM_006186.4(NR4A2):c.325dup (p.Gln109fs) duplication Inborn genetic diseases [RCV001266179]|Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism [RCV002260695]|Neurodevelopmental disorder [RCV001724280]|not provided [RCV002275338] Chr2:156329861..156329862 [GRCh38]
Chr2:157186373..157186374 [GRCh37]
Chr2:2q24.1		 pathogenic
GRCh37/hg19 2q24.1(chr2:156976385-157350281)x1 copy number loss not provided [RCV000848812] Chr2:156976385..157350281 [GRCh37]
Chr2:2q24.1		 uncertain significance
NM_006186.4(NR4A2):c.512C>T (p.Ser171Phe) single nucleotide variant not provided [RCV003126409] Chr2:156329675 [GRCh38]
Chr2:157186187 [GRCh37]
Chr2:2q24.1		 uncertain significance
miRNA Target Status

Confirmed Target Of
miRNA GeneMature miRNAMethod NameResult TypeData TypeSupport TypePMID
MIR19Ahsa-miR-19a-3pMirecordsexternal_infoNANA19885849
MIR217hsa-miR-217Mirtarbaseexternal_infoLuciferase reporter assay//MicroarrayFunctional MTI19885849
MIR217hsa-miR-217Mirecordsexternal_infoNANA19885849
MIR372hsa-miR-372-5pMirecordsexternal_infoNANA19885849
MIR302Dhsa-miR-302d-5pMirecordsexternal_infoNANA19885849

Predicted Target Of
Summary Value
Count of predictions:3364
Count of miRNA genes:988
Interacting mature miRNAs:1215
Transcripts:ENST00000339562, ENST00000406048, ENST00000409108, ENST00000409572, ENST00000417764, ENST00000417972, ENST00000421709, ENST00000424077, ENST00000426264, ENST00000429376, ENST00000539077
Prediction methods:Microtar, Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

Markers in Region
D2S2729  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh372157,181,701 - 157,182,048UniSTSGRCh37
Build 362156,889,947 - 156,890,294RGDNCBI36
Celera2150,795,056 - 150,795,401RGD
Cytogenetic Map2q22-q23UniSTS
HuRef2149,066,962 - 149,067,307UniSTS
Whitehead-YAC Contig Map2 UniSTS
PMC109903P2  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh372157,182,683 - 157,183,423UniSTSGRCh37
Build 362156,890,929 - 156,891,669RGDNCBI36
Celera2150,796,036 - 150,796,775RGD
Cytogenetic Map2q22-q23UniSTS
HuRef2149,067,942 - 149,068,681UniSTS
G15958  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh372157,182,037 - 157,182,242UniSTSGRCh37
Build 362156,890,283 - 156,890,488RGDNCBI36
Celera2150,795,390 - 150,795,595RGD
Cytogenetic Map2q22-q23UniSTS
HuRef2149,067,296 - 149,067,501UniSTS
Nr4a2  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh372157,182,486 - 157,182,713UniSTSGRCh37
Celera2150,795,839 - 150,796,066UniSTS
HuRef2149,067,745 - 149,067,972UniSTS


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system sensory system visual system adipose tissue appendage entire extraembryonic component pharyngeal arch
High 1 2 10
Medium 1000 1705 1007 236 412 147 2725 637 1685 121 839 1024 92 935 1819
Low 1438 1110 711 382 1352 312 1611 1518 2005 295 600 584 82 1 269 967 5 2
Below cutoff 1 176 5 4 173 4 20 42 39 3 9 4 1 2 1

Sequence

Nucleotide Sequences
RefSeq Transcripts NG_011821 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_006186 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_173173 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_005246621 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_006712553 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_011511246 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_017004219 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_017004220 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_047444551 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_047444554 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_047444555 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_047444557 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_047444558 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_047444559 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_054342296 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_054342297 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_054342298 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_054342299 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_054342300 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_054342301 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_054342302 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XR_001738751 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XR_001738752 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XR_427087 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
GenBank Nucleotide AB017586 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AB019433 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AC074099 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AK223625 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AK291456 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AK299439 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AK309786 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC009288 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC066890 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BM922519 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CH471058 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CP068276 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  DA093733 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  FJ643484 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  FJ643485 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  HI574334 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  HI574340 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  HQ692824 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  HQ709176 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  KT584584 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  KU178238 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  KU178239 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  S77154 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  X75918 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles

Reference Sequences
RefSeq Acc Id: ENST00000339562   ⟹   ENSP00000344479
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl2156,324,437 - 156,332,721 (-)Ensembl
RefSeq Acc Id: ENST00000406048   ⟹   ENSP00000385379
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl2156,327,904 - 156,330,121 (-)Ensembl
RefSeq Acc Id: ENST00000409108   ⟹   ENSP00000386993
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl2156,325,744 - 156,330,707 (-)Ensembl
RefSeq Acc Id: ENST00000409572   ⟹   ENSP00000386747
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl2156,325,098 - 156,342,348 (-)Ensembl
RefSeq Acc Id: ENST00000417764   ⟹   ENSP00000415632
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl2156,325,100 - 156,330,788 (-)Ensembl
RefSeq Acc Id: ENST00000417972   ⟹   ENSP00000394671
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl2156,325,100 - 156,331,965 (-)Ensembl
RefSeq Acc Id: ENST00000421709   ⟹   ENSP00000388120
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl2156,329,504 - 156,332,720 (-)Ensembl
RefSeq Acc Id: ENST00000424077   ⟹   ENSP00000406808
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl2156,329,413 - 156,332,713 (-)Ensembl
RefSeq Acc Id: ENST00000426264   ⟹   ENSP00000389986
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl2156,325,082 - 156,332,714 (-)Ensembl
RefSeq Acc Id: ENST00000429376   ⟹   ENSP00000410952
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl2156,325,744 - 156,330,721 (-)Ensembl
RefSeq Acc Id: ENST00000675870   ⟹   ENSP00000502739
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl2156,325,100 - 156,330,788 (-)Ensembl
RefSeq Acc Id: ENST00000700228   ⟹   ENSP00000514865
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl2156,324,908 - 156,332,762 (-)Ensembl
RefSeq Acc Id: ENST00000700229   ⟹   ENSP00000514866
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl2156,325,252 - 156,328,415 (-)Ensembl
RefSeq Acc Id: ENST00000700230   ⟹   ENSP00000514867
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl2156,325,344 - 156,329,619 (-)Ensembl
RefSeq Acc Id: ENST00000700231   ⟹   ENSP00000514868
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl2156,325,352 - 156,332,684 (-)Ensembl
RefSeq Acc Id: NM_006186   ⟹   NP_006177
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh382156,324,437 - 156,332,721 (-)NCBI
GRCh372157,180,944 - 157,189,287 (-)ENTREZGENE
Build 362156,889,195 - 156,897,446 (-)NCBI Archive
HuRef2149,066,205 - 149,074,545 (-)ENTREZGENE
CHM1_12157,187,025 - 157,195,368 (-)NCBI
T2T-CHM13v2.02156,777,128 - 156,785,409 (-)NCBI
Sequence:
RefSeq Acc Id: NM_173173   ⟹   NP_775265
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh382156,324,437 - 156,332,721 (-)NCBI
T2T-CHM13v2.02156,777,128 - 156,785,409 (-)NCBI
Sequence:
RefSeq Acc Id: XM_005246621   ⟹   XP_005246678
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh382156,324,437 - 156,332,721 (-)NCBI
GRCh372157,180,944 - 157,189,287 (-)NCBI
Sequence:
RefSeq Acc Id: XM_006712553   ⟹   XP_006712616
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh382156,324,437 - 156,332,721 (-)NCBI
Sequence:
RefSeq Acc Id: XM_011511246   ⟹   XP_011509548
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh382156,324,437 - 156,332,721 (-)NCBI
Sequence:
RefSeq Acc Id: XM_047444551   ⟹   XP_047300507
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh382156,324,437 - 156,332,721 (-)NCBI
RefSeq Acc Id: XM_047444554   ⟹   XP_047300510
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh382156,324,437 - 156,332,721 (-)NCBI
RefSeq Acc Id: XM_047444555   ⟹   XP_047300511
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh382156,324,437 - 156,332,465 (-)NCBI
RefSeq Acc Id: XM_047444557   ⟹   XP_047300513
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh382156,324,437 - 156,332,464 (-)NCBI
RefSeq Acc Id: XM_047444558   ⟹   XP_047300514
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh382156,324,437 - 156,332,465 (-)NCBI
RefSeq Acc Id: XM_047444559   ⟹   XP_047300515
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh382156,326,147 - 156,332,721 (-)NCBI
RefSeq Acc Id: XM_054342296   ⟹   XP_054198271
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.02156,777,128 - 156,785,409 (-)NCBI
RefSeq Acc Id: XM_054342297   ⟹   XP_054198272
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.02156,777,128 - 156,785,409 (-)NCBI
RefSeq Acc Id: XM_054342298   ⟹   XP_054198273
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.02156,777,128 - 156,785,153 (-)NCBI
RefSeq Acc Id: XM_054342299   ⟹   XP_054198274
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.02156,777,128 - 156,785,409 (-)NCBI
RefSeq Acc Id: XM_054342300   ⟹   XP_054198275
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.02156,777,128 - 156,785,152 (-)NCBI
RefSeq Acc Id: XM_054342301   ⟹   XP_054198276
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.02156,777,128 - 156,785,153 (-)NCBI
RefSeq Acc Id: XM_054342302   ⟹   XP_054198277
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.02156,778,836 - 156,785,409 (-)NCBI
Protein Sequences
Protein RefSeqs NP_006177 (Get FASTA)   NCBI Sequence Viewer  
  NP_775265 (Get FASTA)   NCBI Sequence Viewer  
  XP_005246678 (Get FASTA)   NCBI Sequence Viewer  
  XP_006712616 (Get FASTA)   NCBI Sequence Viewer  
  XP_011509548 (Get FASTA)   NCBI Sequence Viewer  
  XP_047300507 (Get FASTA)   NCBI Sequence Viewer  
  XP_047300510 (Get FASTA)   NCBI Sequence Viewer  
  XP_047300511 (Get FASTA)   NCBI Sequence Viewer  
  XP_047300513 (Get FASTA)   NCBI Sequence Viewer  
  XP_047300514 (Get FASTA)   NCBI Sequence Viewer  
  XP_047300515 (Get FASTA)   NCBI Sequence Viewer  
  XP_054198271 (Get FASTA)   NCBI Sequence Viewer  
  XP_054198272 (Get FASTA)   NCBI Sequence Viewer  
  XP_054198273 (Get FASTA)   NCBI Sequence Viewer  
  XP_054198274 (Get FASTA)   NCBI Sequence Viewer  
  XP_054198275 (Get FASTA)   NCBI Sequence Viewer  
  XP_054198276 (Get FASTA)   NCBI Sequence Viewer  
  XP_054198277 (Get FASTA)   NCBI Sequence Viewer  
GenBank Protein AAB33999 (Get FASTA)   NCBI Sequence Viewer  
  AAH09288 (Get FASTA)   NCBI Sequence Viewer  
  AAH66890 (Get FASTA)   NCBI Sequence Viewer  
  AAY24203 (Get FASTA)   NCBI Sequence Viewer  
  ACN32470 (Get FASTA)   NCBI Sequence Viewer  
  ACN32471 (Get FASTA)   NCBI Sequence Viewer  
  ADZ17335 (Get FASTA)   NCBI Sequence Viewer  
  ADZ17383 (Get FASTA)   NCBI Sequence Viewer  
  ALQ33696 (Get FASTA)   NCBI Sequence Viewer  
  ALQ33697 (Get FASTA)   NCBI Sequence Viewer  
  BAA75666 (Get FASTA)   NCBI Sequence Viewer  
  BAA77328 (Get FASTA)   NCBI Sequence Viewer  
  BAD97345 (Get FASTA)   NCBI Sequence Viewer  
  BAF84145 (Get FASTA)   NCBI Sequence Viewer  
  BAH13033 (Get FASTA)   NCBI Sequence Viewer  
  CAA53518 (Get FASTA)   NCBI Sequence Viewer  
  CBX47656 (Get FASTA)   NCBI Sequence Viewer  
  CBX47659 (Get FASTA)   NCBI Sequence Viewer  
  EAX11454 (Get FASTA)   NCBI Sequence Viewer  
  EAX11455 (Get FASTA)   NCBI Sequence Viewer  
Ensembl Protein ENSP00000344479
  ENSP00000344479.4
  ENSP00000386747.1
  ENSP00000386993
  ENSP00000386993.2
  ENSP00000388120.2
  ENSP00000389986
  ENSP00000389986.1
  ENSP00000394671.1
  ENSP00000406808.1
  ENSP00000410952.1
  ENSP00000415632
  ENSP00000415632.1
  ENSP00000502739.1
  ENSP00000514865
  ENSP00000514865.1
  ENSP00000514866.1
  ENSP00000514867.1
  ENSP00000514868
  ENSP00000514868.1
GenBank Protein P43354 (Get FASTA)   NCBI Sequence Viewer  
Reference Protein Sequences
RefSeq Acc Id: NP_006177   ⟸   NM_006186
- Peptide Label: isoform a
- UniProtKB: Q53RZ2 (UniProtKB/Swiss-Prot),   Q16311 (UniProtKB/Swiss-Prot),   Q6NXU0 (UniProtKB/Swiss-Prot),   P43354 (UniProtKB/Swiss-Prot),   F1D8N6 (UniProtKB/TrEMBL),   Q53EL4 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: XP_005246678   ⟸   XM_005246621
- Peptide Label: isoform X1
- UniProtKB: B7Z5U7 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: XP_006712616   ⟸   XM_006712553
- Peptide Label: isoform X2
- UniProtKB: B7Z5U7 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: XP_011509548   ⟸   XM_011511246
- Peptide Label: isoform X4
- UniProtKB: F8W6I3 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: NP_775265   ⟸   NM_173173
- Peptide Label: isoform d
- UniProtKB: A0A8V8TR19 (UniProtKB/TrEMBL)
RefSeq Acc Id: ENSP00000406808   ⟸   ENST00000424077
RefSeq Acc Id: ENSP00000389986   ⟸   ENST00000426264
RefSeq Acc Id: ENSP00000410952   ⟸   ENST00000429376
RefSeq Acc Id: ENSP00000394671   ⟸   ENST00000417972
RefSeq Acc Id: ENSP00000415632   ⟸   ENST00000417764
RefSeq Acc Id: ENSP00000344479   ⟸   ENST00000339562
RefSeq Acc Id: ENSP00000385379   ⟸   ENST00000406048
RefSeq Acc Id: ENSP00000386747   ⟸   ENST00000409572
RefSeq Acc Id: ENSP00000386993   ⟸   ENST00000409108
RefSeq Acc Id: ENSP00000388120   ⟸   ENST00000421709
RefSeq Acc Id: ENSP00000502739   ⟸   ENST00000675870
RefSeq Acc Id: XP_047300510   ⟸   XM_047444554
- Peptide Label: isoform X3
- UniProtKB: F1DAL2 (UniProtKB/TrEMBL)
RefSeq Acc Id: XP_047300507   ⟸   XM_047444551
- Peptide Label: isoform X8
- UniProtKB: Q53RZ2 (UniProtKB/Swiss-Prot),   Q16311 (UniProtKB/Swiss-Prot),   P43354 (UniProtKB/Swiss-Prot),   Q6NXU0 (UniProtKB/Swiss-Prot),   F1D8N6 (UniProtKB/TrEMBL)
RefSeq Acc Id: XP_047300514   ⟸   XM_047444558
- Peptide Label: isoform X6
RefSeq Acc Id: XP_047300511   ⟸   XM_047444555
- Peptide Label: isoform X3
- UniProtKB: F1DAL2 (UniProtKB/TrEMBL)
RefSeq Acc Id: XP_047300513   ⟸   XM_047444557
- Peptide Label: isoform X5
RefSeq Acc Id: XP_047300515   ⟸   XM_047444559
- Peptide Label: isoform X7
RefSeq Acc Id: ENSP00000514868   ⟸   ENST00000700231
RefSeq Acc Id: ENSP00000514865   ⟸   ENST00000700228
RefSeq Acc Id: ENSP00000514867   ⟸   ENST00000700230
RefSeq Acc Id: ENSP00000514866   ⟸   ENST00000700229
RefSeq Acc Id: XP_054198272   ⟸   XM_054342297
- Peptide Label: isoform X2
RefSeq Acc Id: XP_054198274   ⟸   XM_054342299
- Peptide Label: isoform X4
RefSeq Acc Id: XP_054198271   ⟸   XM_054342296
- Peptide Label: isoform X1
RefSeq Acc Id: XP_054198276   ⟸   XM_054342301
- Peptide Label: isoform X6
RefSeq Acc Id: XP_054198273   ⟸   XM_054342298
- Peptide Label: isoform X3
RefSeq Acc Id: XP_054198275   ⟸   XM_054342300
- Peptide Label: isoform X5
RefSeq Acc Id: XP_054198277   ⟸   XM_054342302
- Peptide Label: isoform X7
Protein Domains
NR LBD   Nuclear receptor

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P43354-F1-model_v2 AlphaFold P43354 1-598 view protein structure

Promoters
RGD ID:6861778
Promoter ID:EPDNEW_H4054
Type:initiation region
Name:NR4A2_1
Description:nuclear receptor subfamily 4 group A member 2
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Human AssemblyChrPosition (strand)Source
GRCh382156,332,684 - 156,332,744EPDNEW
RGD ID:6797887
Promoter ID:HG_KWN:35485
Type:CpG-Island
SO ACC ID:SO:0000170
Source:MPROMDB
Tissues & Cell Lines:HeLa_S3
Transcripts:OTTHUMT00000332644
Position:
Human AssemblyChrPosition (strand)Source
Build 362156,894,611 - 156,895,111 (-)MPROMDB
RGD ID:6797284
Promoter ID:HG_KWN:35486
Type:Non-CpG
SO ACC ID:SO:0000170
Source:MPROMDB
Tissues & Cell Lines:HeLa_S3
Transcripts:ENST00000409108,   OTTHUMT00000332645,   OTTHUMT00000333153
Position:
Human AssemblyChrPosition (strand)Source
Build 362156,895,211 - 156,895,711 (-)MPROMDB
RGD ID:6797883
Promoter ID:HG_KWN:35487
Type:CpG-Island
SO ACC ID:SO:0000170
Source:MPROMDB
Tissues & Cell Lines:CD4+TCell,   CD4+TCell_12Hour,   K562,   Lymphoblastoid,   NB4
Transcripts:OTTHUMT00000332643
Position:
Human AssemblyChrPosition (strand)Source
Build 362156,896,776 - 156,897,542 (-)MPROMDB
RGD ID:6797884
Promoter ID:HG_KWN:35488
Type:CpG-Island
SO ACC ID:SO:0000170
Source:MPROMDB
Tissues & Cell Lines:CD4+TCell,   CD4+TCell_12Hour,   CD4+TCell_2Hour,   HeLa_S3,   K562,   Lymphoblastoid,   NB4
Transcripts:NM_006186,   OTTHUMT00000332639,   OTTHUMT00000332641,   OTTHUMT00000332642,   UC002TYX.2,   UC002TYY.2,   UC002TZA.2
Position:
Human AssemblyChrPosition (strand)Source
Build 362156,897,411 - 156,898,417 (-)MPROMDB
RGD ID:6797292
Promoter ID:HG_KWN:35489
Type:CpG-Island
SO ACC ID:SO:0000170
Source:MPROMDB
Tissues & Cell Lines:CD4+TCell,   CD4+TCell_12Hour,   HeLa_S3,   K562,   Lymphoblastoid,   NB4
Transcripts:ENST00000409572,   UC002TZB.1
Position:
Human AssemblyChrPosition (strand)Source
Build 362156,905,356 - 156,907,627 (-)MPROMDB

Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:7981 AgrOrtholog
COSMIC NR4A2 COSMIC
Ensembl Genes ENSG00000153234 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Ensembl Transcript ENST00000339562 ENTREZGENE
  ENST00000339562.9 UniProtKB/Swiss-Prot
  ENST00000409108 ENTREZGENE
  ENST00000409108.6 UniProtKB/TrEMBL
  ENST00000409572.5 UniProtKB/Swiss-Prot
  ENST00000417764 ENTREZGENE
  ENST00000417764.5 UniProtKB/TrEMBL
  ENST00000417972.5 UniProtKB/TrEMBL
  ENST00000421709.2 UniProtKB/TrEMBL
  ENST00000424077.1 UniProtKB/TrEMBL
  ENST00000426264 ENTREZGENE
  ENST00000426264.5 UniProtKB/Swiss-Prot
  ENST00000429376.5 UniProtKB/TrEMBL
  ENST00000675870.1 UniProtKB/TrEMBL
  ENST00000700228 ENTREZGENE
  ENST00000700228.1 UniProtKB/TrEMBL
  ENST00000700229.1 UniProtKB/TrEMBL
  ENST00000700230.1 UniProtKB/TrEMBL
  ENST00000700231 ENTREZGENE
  ENST00000700231.1 UniProtKB/TrEMBL
Gene3D-CATH 1.10.565.10 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  3.30.50.10 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
GTEx ENSG00000153234 GTEx
HGNC ID HGNC:7981 ENTREZGENE
Human Proteome Map NR4A2 Human Proteome Map
InterPro NHR-like_dom_sf UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Nuc_orph_rcpt UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Nucl_hrmn_rcpt_lig-bd UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Nuclear_hrmn_rcpt UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  NURR_rcpt UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Znf_hrmn_rcpt UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Znf_NHR/GATA UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report hsa:4929 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
NCBI Gene 4929 ENTREZGENE
OMIM 601828 OMIM
PANTHER NUCLEAR HORMONE RECEPTOR UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  NUCLEAR RECEPTOR SUBFAMILY 4 GROUP A MEMBER 2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Pfam Hormone_recep UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  zf-C4 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PharmGKB PA31762 PharmGKB
PRINTS NUCLEARECPTR UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  NURRNUCRCPTR UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  STRDHORMONER UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  STROIDFINGER UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PROSITE NR_LBD UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  NUCLEAR_REC_DBD_1 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  NUCLEAR_REC_DBD_2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
SMART HOLI UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  ZnF_C4 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Superfamily-SCOP Glucocorticoid receptor-like (DNA-binding domain) UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  SSF48508 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
UniProt A0A0S2Z418_HUMAN UniProtKB/TrEMBL
  A0A8V8TPF8_HUMAN UniProtKB/TrEMBL
  A0A8V8TPV9_HUMAN UniProtKB/TrEMBL
  A0A8V8TR19 ENTREZGENE, UniProtKB/TrEMBL
  B7Z5U7 ENTREZGENE, UniProtKB/TrEMBL
  C0KWD1_HUMAN UniProtKB/TrEMBL
  C0KWD2_HUMAN UniProtKB/TrEMBL
  C9IYM5_HUMAN UniProtKB/TrEMBL
  C9J8W4_HUMAN UniProtKB/TrEMBL
  C9JWQ1_HUMAN UniProtKB/TrEMBL
  E9PBQ4_HUMAN UniProtKB/TrEMBL
  F1D8N6 ENTREZGENE, UniProtKB/TrEMBL
  F1DAL2 ENTREZGENE, UniProtKB/TrEMBL
  F8W6I3 ENTREZGENE, UniProtKB/TrEMBL
  NR4A2_HUMAN UniProtKB/Swiss-Prot, ENTREZGENE
  Q16311 ENTREZGENE
  Q53EL4 ENTREZGENE, UniProtKB/TrEMBL
  Q53RZ2 ENTREZGENE
  Q6NXU0 ENTREZGENE
UniProt Secondary Q16311 UniProtKB/Swiss-Prot
  Q53RZ2 UniProtKB/Swiss-Prot
  Q6NXU0 UniProtKB/Swiss-Prot


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2015-11-24 NR4A2  nuclear receptor subfamily 4 group A member 2  NR4A2  nuclear receptor subfamily 4, group A, member 2  Symbol and/or name change 5135510 APPROVED